Global Neuromodulation Market to Reach $8.2 Billion by 2026

News provided by

Aug 03, 2021, 10:55 ET

SAN FRANCISCO, Aug. 3, 2021 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Neuromodulation - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
Edition: 8; Released: May 2021
Executive Pool: 10472
Companies: 83 - Players covered include Abbott Laboratories; Aleva Neurotherapeutics SA; BioControl Medical; Bioness Inc; Boston Scientific Corporation; Cefaly; electroCore, Inc.; Inspire Medical Systems, Inc.; LivaNova PLC; Medtronic; Neuronetics; NeuroPace, Inc.; NeuroSigma, Inc.; Nevro Corporation; Respicardia, Inc; Stimwave LLC; Synapse Biomedical, Inc. and Others.
Coverage: All major geographies and key segments
Segments: Technology (Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagus Nerve Stimulation, Transcutaneous Electrical Nerve Stimulation, Repetitive Transcranial Magnetic Stimulation, Other Technologies); Application (Chronic Pain, Failed Back Syndrome, Depression, Epilepsy, Parkinson`s Disease, Migraine, Other Applications)
Geographies: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Neuromodulation Market to Reach $8.2 Billion by 2026
Neuromodulation functions through the active stimulation of the nerves to generate a biological reaction or through the direct application of targeted pharmaceutical agents in small doses to the area of action. Neurostimulation devices work by applying electrodes to the spinal cord, brain, or to the peripheral nerves. Growth in the global market is being fueled by the expanding base of people suffering from various illnesses such as urinary incontinence, Parkinson's disease, spinal cord damage, migraine, and epilepsy. The market is also expected to gain from the rising awareness regarding neurodegenerative and neurological disorders, and expanding application areas. The rising incidence of depression and its associated symptoms, especially among millennials, opens up new opportunities. Furthermore, increasing aging population globally, and growing awareness of the efficacy and safety of neurostimulator devices are aiding market growth.

Amid the COVID-19 crisis, the global market for Neuromodulation estimated at US$5.1 Billion in the year 2020, is projected to reach a revised size of US$8.2 Billion by 2026, growing at a CAGR of 8.2% over the analysis period. Spinal Cord Stimulation, one of the segments analyzed in the report, is projected to grow at a 8.3% CAGR to reach US$3.9 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Deep Brain Stimulation segment is readjusted to a revised 8.6% CAGR for the next 7-year period. This segment currently accounts for a 16.7% share of the global Neuromodulation market. Spinal Cord Stimulation (SCS) segment is making robust gains, driven by widespread availability of a broad range of commercial SCS products and the expanding range of applications for these devices. SCS systems are used in neurological problems such as arachnoiditis, neuropathy, neuritis, nerve damage, problems related to failed-back surgery, and complex regional pain syndrome. Deep brain stimulation is expected to register considerable growth, owing to its use in the treatment of various neurological conditions such as depression, tremor, Parkinson's disease, and others. DBS technique is already approved by the US FDA for treating obsessive-compulsive disorder, dystonia, essential tremor, epilepsy, and Parkinson's disease.

The U.S. Market is Estimated at $2.6 Billion in 2021, While China is Forecast to Reach $597.6 Million by 2026
The Neuromodulation market in the U.S. is estimated at US$2.6 Billion in the year 2021. The country currently accounts for a 48.43% share in the global market. China, the world's second largest economy, is forecast to reach an estimated market size of US$597.6 Million in the year 2026 trailing a CAGR of 10% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.9% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR while Rest of European market (as defined in the study) will reach US$663.5 Million by the end of the analysis period. The US represents the leading regional market, fueled by technological advancements and significant investments made by leading companies for product development. Besides the increasing incidence of neurological diseases and expanding geriatric population, increasing spending on healthcare sector, positive reimbursement framework and presence of several leading industry players in the region are fueling market growth. Highly developed healthcare infrastructure, increased prevalence of diseases and growing approvals for non-invasive devices in Europe have been adding to the demand for these devices. Growth in the Asia-Pacific region is supported by significant prevalence of neurological disorders, the research activities underway, growing investments by private and public players, and increasing initiatives for improving awareness about mental health.

Sacral Nerve Stimulation Segment to Reach $1.2 Billion by 2026
In the global Sacral Nerve Stimulation segment, USA, Canada, Japan, China and Europe will drive the 7.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$696.3 Million in the year 2020 will reach a projected size of US$1.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$70.2 Million by the year 2026. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
[email protected]

SOURCE Global Industry Analysts, Inc.